Welcome to LookChem.com Sign In|Join Free

CAS

  • or

55869-99-3

Post Buying Request

55869-99-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

55869-99-3 Usage

Description

ANISODAMINE is a compound that belongs to the class of tropane alkaloids, which are naturally occurring substances found in certain plants. It is a racemic mixture of diastereomers, meaning it consists of equal parts of two different stereoisomers that are mirror images of each other. ANISODAMINE has been recognized for its various pharmacological properties and potential applications in the medical field.

Uses

Used in Pharmaceutical Industry:
ANISODAMINE is used as a precursor in the synthesis of various pharmaceutical compounds, particularly those with anticholinergic properties. Its ability to inhibit cholinesterases makes it a valuable starting material for developing drugs that can be used to treat conditions related to an overactive nervous system or excessive secretion of certain neurotransmitters.
Used in Neurological Applications:
ANISODAMINE is used as a therapeutic agent for neurological disorders characterized by excessive cholinergic activity. Its inhibitory effect on cholinesterases can help in managing symptoms associated with conditions such as Parkinson's disease, Alzheimer's disease, and other movement disorders.
Used in Drug Development:
ANISODAMINE serves as a key component in the development of new drugs targeting the cholinergic system. Researchers can use this compound to design and synthesize novel medications with improved efficacy, safety, and selectivity for treating various neurological and psychiatric conditions.
Used in Research and Development:
ANISODAMINE is utilized as a research tool in the study of cholinergic neurotransmission and the development of new drugs targeting this system. Its unique properties make it an important compound for understanding the mechanisms of action and potential therapeutic applications of cholinergic modulators.

Biochem/physiol Actions

Anisodamine is a non‐specific cholinergic antagonist. It is considered less efficient and less toxic than atropine. Anisodamine interferes with liposome structure and affects cell membrane. It might act as an anti‐oxidant, in protecting against the damage caused by free radicals. Anisodamine is known to reduce cardiac conduction and also prevents arrhythmia. It can block thromboxane synthesis and might possess anti‐thrombotic function. Anisodamine has been useful in a number therapies including septic shock, circulatory disorders, organophosphorus poisoning, opiate addiction, snake bite and radiation damage. Disorders, such as migraine, gastric ulcers, rheumatoid arthritis, gastrointestinal colic, eclampsia, respiratory diseases, acute glomerular nephritis and obstructive jaundice can be treated with the help of anisodamine.

Check Digit Verification of cas no

The CAS Registry Mumber 55869-99-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,5,8,6 and 9 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 55869-99:
(7*5)+(6*5)+(5*8)+(4*6)+(3*9)+(2*9)+(1*9)=183
183 % 10 = 3
So 55869-99-3 is a valid CAS Registry Number.
InChI:InChI=1/C17H22O3/c18-11-16(14-4-2-1-3-5-14)17(19)20-15-9-12-6-7-13(8-12)10-15/h1-5,12-13,15-16,18H,6-11H2

55869-99-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name (-)-Anisodamine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:55869-99-3 SDS

55869-99-3Relevant articles and documents

Evidence for Modulation of Oxygen Rebound Rate in Control of Outcome by Iron(II)- And 2-Oxoglutarate-Dependent Oxygenases

Pan, Juan,Wenger, Eliott S.,Matthews, Megan L.,Pollock, Christopher J.,Bhardwaj, Minakshi,Kim, Amelia J.,Allen, Benjamin D.,Grossman, Robert B.,Krebs, Carsten,Martin Bollinger

supporting information, p. 15153 - 15165 (2019/10/19)

Iron(II)- and 2-oxoglutarate-dependent (Fe/2OG) oxygenases generate iron(IV)-oxo (ferryl) intermediates that can abstract hydrogen from aliphatic carbons (R-H). Hydroxylation proceeds by coupling of the resultant substrate radical (Ra€¢) and oxygen of the Fe(III)-OH complex ("oxygen rebound"). Nonhydroxylation outcomes result from different fates of the Fe(III)-OH/R?state; for example, halogenation results from R?coupling to a halogen ligand cis to the hydroxide. We previously suggested that halogenases control substrate-cofactor disposition to disfavor oxygen rebound and permit halogen coupling to prevail. Here, we explored the general implication that, when a ferryl intermediate can ambiguously target two substrate carbons for different outcomes, rebound to the site capable of the alternative outcome should be slower than to the adjacent, solely hydroxylated site. We evaluated this prediction for (i) the halogenase SyrB2, which exclusively hydroxylates C5 of norvaline appended to its carrier protein but can either chlorinate or hydroxylate C4 and (ii) two bifunctional enzymes that normally hydroxylate one carbon before coupling that oxygen to a second carbon (producing an oxacycle) but can, upon encountering deuterium at the first site, hydroxylate the second site instead. In all three cases, substrate hydroxylation incorporates a greater fraction of solvent-derived oxygen at the site that can also undergo the alternative outcome than at the other site, most likely reflecting an increased exchange of the initially O2-derived oxygen ligand in the longer-lived Fe(III)-OH/R?states. Suppression of rebound may thus be generally important for nonhydroxylation outcomes by these enzymes.

Preparative separation of four isomers of synthetic anisodamine by HPLC and diastereomer crystallization

Wu, Tong,Zhu, Jiu-Xin,Wei, Qian,Li, Ping,Wang, Li-Bo,Huang, Jian,Wang, Jin-Hui,Tang, Li-Ke,Wu, Li-Jun,Li, Chang,Han, Wei-Na

, p. 11 - 20 (2018/11/23)

Anisodamine (654-1), a well-known cholinergic antagonist, is marketed as synthetic anisodamine (mixture of four isomers, 654-2) in China. To preparative resolution and comparison of the bioactivities of the four isomers of synthetic anisodamine, current work explores an economic and effective separation method by using preparative high performance liquid chromatography (HPLC) and diastereomer crystallization. Their absolute configurations were established by single-crystal X-ray diffraction and circular dichroism method. The purities of each isomer were more than 95%. Among them, 654-2-A2 (6R, 2′S configuration) exhibited better effect on cabachol preconditioned small intestine tension more than 654-2 and other isomers. The direct separation method without using HPLC was tried as well, which was still on progress. This is the first report of the method for preparative separation of four isomers of synthetic anisodamine which could be used for large-scale production in industry.

Absolute configuration of natural diastereoisomers of 6β- hydroxyhyoscyamine by vibrational circular dichroism

Munoz, Marcelo A.,Munoz, Orlando,Joseph-Nathan, Pedro

, p. 1335 - 1340 (2008/12/20)

The absolute configuration of the two natural diastereoisomers of 6β-hydroxyhyoscyamine has been determined using vibrational circular dichroism (VCD) spectroscopy. The predicted VCD and IR spectra of (3R,6R,2′S)-6β-hydroxyhyoscyamine (1) and (3S,6S,2′S)-6β- hydroxyhyoscyamine (2) were calculated using density functional theory (DFT) with the B3LYP functional and 6-31G(d) basis set and considering the eight lower energy conformations of each diastereoisomer. In both cases, the first four conformers showed the N-Me group in the syn orientation, permitting the formation of a hydrogen bond between the hydroxy group at the tropane ring and the tertiary nitrogen atom. In addition the eight conformers showed an intramolecular hydrogen bond between the hydroxy and carbonyl groups of the tropic ester moiety. The calculated IR spectra of both molecules showed good agreement with the experimental spectra, while comparison of the experimental and calculated VCD spectra showed that the absolute configuration of dextrorotatory 6β-hydroxyhyoscyamine is (3R,6R,2′S), while the levorotatory isomer is (3S,6S,2′S).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 55869-99-3